Abstract:Background: Heightened scrutiny surrounds the inappropriate use of proton pump inhibitors (PPIs) due to concerns regarding potential serious adverse effects (AEs). Understanding the impact of these AEs on real-world practice is crucial. This study aimed to assess physicians' perceptions, experiences, awareness, and beliefs regarding published data on potential AEs associated with PPIs. Additionally, it sought to determine alterations in PPI prescribing patterns resulting from these AEs, explore attitudes towards PPI use, and ascertain recommendations for PPI use in clinical scenarios with varying levels of risk for upper gastrointestinal bleeding (UGIB). Method: A quantitative, cross-sectional study utilized a self-administered questionnaire, inviting 282 physicians from 55 primary healthcare centers and 334 internal medicine physicians from seven governmental hospitals to participate. Results: With a response rate of 87.8% (541/616), 74% (95% CI: 70.2–77.7) of respondents were somewhat or very familiar with published data on PPI AEs. Among the familiar, 69.5% (CI: 65.2–73.5) had somewhat or very much changed their PPI prescribing patterns. General concerns about AEs when prescribing PPIs were reported by 62% (CI: 56.7–65.1). Respondents displayed awareness of a median (IQR) of 15 (9) different AEs associated with long-term PPI use, including osteoporosis or osteopenia (90.2%), hypomagnesemia (81.5%), vitamin B12 deficiency (80.6%), and bone fracture (80.0%). Respondents believed that PPIs elevate the risk for a median (IQR) of 7 (6) different AEs, with osteoporosis or osteopenia (81.8%) being the most common, followed by hypomagnesemia (67.1%), and vitamin B12 deficiency (62.3%). The most common strategies for PPI de-escalation were PPI discontinuation (61%) and using PPI on-demand/as-needed (57.9%). The majority (87.4%) agreed or strongly agreed that PPI overuse is prevalent in Kuwait and 78.2% emphasized the necessity for large-scale education on rational PPI use for medical staff and the public. In the UGIB prevention scenarios, 43.6% recommended appropriately the PPI discontinuation in the minimal-risk scenario, while 56% recommended appropriately the PPI continuation in the high-risk scenario. Associations and comparative analyses revealed predictors influencing physicians' practices and attitudes toward PPI usage. Conclusion: These findings lay the foundation for future research and targeted interventions aimed at optimizing PPI prescribing practices and ensuring patient safety.

S2316 Appropriate Use of PPIs in the Outpatient Setting and the Consequences of their Long-term Use

Retrospective Comments on Prescriptions of Oral Proton Pump Inhibitors for Outpatients in A General Hospital

The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

Proton Pump Inhibitors: Review of Emerging Concerns

Understanding the health risks and emerging concerns associated with the use of long-term proton pump inhibitors

Primary and Specialty Care Trainees’ Perceptions About Proton Pump Inhibitor Use

Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle

Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors

Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study

Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns

Proton pump inhibitors from clinical pharmacists point of view

Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

Appropriateness of Proton-Pump Inhibitor Usage among Hospitalized Patients in a Johor Government Hospital

Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe

Potential Risks Associated With Long-term Use of Proton Pump Inhibitors and the Maintenance Treatment Modality for Patients With Mild Gastroesophageal Reflux Disease

Long Term Risks of Proton Pump Inhibitor Administration: A Literature Review

Prescribing practices for Proton pump inhibitors among primary care physicians in England

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis

The appropriateness of a proton pump inhibitor prescription